CardiacWire

JANUARY 31, 2024

Procedure trends certainly suggest that we’ve entered the TAVR era, but a pair of new studies show that surgical aortic valve replacement (SAVR) is a far better option for many younger and healthier patients who are increasingly seen as TAVR candidates. The post SAVR’s Value in the TAVR Era appeared first on Cardiac Wire.

TAVR 69

TAVR Aortic valve Bicuspid/Mitral Aortic 69

DAIC

FEBRUARY 15, 2024

Food and Drug Administration ( FDA ) confirmed 13 to 1, with 0 abstention that the benefits of Abbott's TriClip™ transcatheter edge-to-edge repair (TEER) system outweighed the risks for the treatment of people with tricuspid regurgitation (TR). On the final question of the benefit of TriClip versus the risk, the vote was 13 to 1 in favor.

Tricuspid 102

Tricuspid Heart Valves Quality of Life Bicuspid/Mitral 102

DAIC

APRIL 30, 2024

Tricuspid Valve Repair Existing literature on national surgical outcomes of isolated tricuspid valve repair or replacement is based on data from over a decade ago and may not reflect current practice results. Analysis of 13,587 patients undergoing isolated tricuspid valve surgery from 2017 to 2023 revealed a 5.5%

TAVR 111

TAVR Aortic valve Tricuspid Coronary Artery Bypass Graft 111

Med Page Today

APRIL 2, 2024

(MedPage Today) -- Abbott said its TriClip transcatheter edge-to-edge repair system snagged FDA approval for treating for tricuspid regurgitation. Medtronic announced that the FDA approved the Evolut FX+ TAVR system, featuring a larger diamond.

Cholesterol 45

Cholesterol TAVR Tricuspid 45

DAIC

JUNE 5, 2024

The sale enhances Edwards’ balance sheet flexibility for disciplined investments in technologies for aortic, mitral, tricuspid and pulmonic patients, as well as new therapeutic areas for interventional heart failure.

Critical Care 105

Critical Care Tricuspid Innovation Bicuspid/Mitral 105

Open Heart

OCTOBER 19, 2022

Objective A novel artificial intelligence-based phenotyping approach to stratify patients with severe aortic stenosis (AS) prior to transcatheter aortic valve replacement (TAVR) has been proposed, based on echocardiographic and haemodynamic data. after TAVR, were available from 247 patients (67.5%). ±15.8 ±15.1 to 94.8%)).

Aortic valve 52

Aortic valve Aortic Stenosis TAVR 52

DAIC

MARCH 15, 2024

Widely recognized for pioneering innovative concepts and techniques in TAVR, Tang has set contemporary standards in the field. His research centers on the comprehensive management of patients post-TAVR, transcatheter mitral and tricuspid valve interventions, and advanced imaging techniques in structural heart disease.

TAVR 105

TAVR Academic Education Cardiovascular Surgery 105